Kimberly-Clark (NYSE:KMB) Price Target Raised to $147.00 at Deutsche Bank Aktiengesellschaft

Kimberly-Clark (NYSE:KMB) had its target price raised by Deutsche Bank Aktiengesellschaft from $146.00 to $147.00 in a report issued on Tuesday morning, Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a hold rating on the stock.

Other equities analysts have also recently issued research reports about the stock. StockNews.com cut shares of Kimberly-Clark from a strong-buy rating to a buy rating in a research note on Tuesday, July 30th. Piper Sandler increased their price objective on shares of Kimberly-Clark from $167.00 to $174.00 and gave the stock an overweight rating in a research note on Thursday, July 11th. JPMorgan Chase & Co. increased their price objective on shares of Kimberly-Clark from $123.00 to $135.00 and gave the stock an underweight rating in a research note on Monday, July 22nd. Argus upgraded shares of Kimberly-Clark to a hold rating in a research note on Friday, July 26th. Finally, Barclays decreased their target price on shares of Kimberly-Clark from $136.00 to $135.00 and set an equal weight rating on the stock in a research note on Friday, July 19th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of Hold and a consensus price target of $147.07.

Kimberly-Clark Stock Performance

Shares of NYSE KMB opened at $142.25 on Tuesday. The firm’s 50-day moving average price is $142.55 and its 200-day moving average price is $137.59. The company has a quick ratio of 0.58, a current ratio of 0.85 and a debt-to-equity ratio of 5.59. The company has a market cap of $47.91 billion, a PE ratio of 21.07, a PEG ratio of 2.98 and a beta of 0.39. Kimberly-Clark has a 52-week low of $116.63 and a 52-week high of $149.30.

Kimberly-Clark (NYSE:KMB) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $1.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.25. Kimberly-Clark had a net margin of 11.28% and a return on equity of 223.55%. The firm had revenue of $5.03 billion for the quarter, compared to the consensus estimate of $5.10 billion. During the same quarter last year, the firm posted $1.65 EPS. The business’s quarterly revenue was down 2.0% compared to the same quarter last year. As a group, analysts anticipate that Kimberly-Clark will post 7.25 EPS for the current year.

Kimberly-Clark Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 2nd. Stockholders of record on Friday, September 6th were given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.43%. The ex-dividend date was Friday, September 6th. Kimberly-Clark’s payout ratio is currently 72.30%.

Insider Activity

In other news, insider Jeffrey P. Melucci sold 37,699 shares of Kimberly-Clark stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $141.42, for a total transaction of $5,331,392.58. Following the sale, the insider now owns 19,935 shares in the company, valued at $2,819,207.70. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, insider Jeffrey P. Melucci sold 37,699 shares of the firm’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $141.42, for a total value of $5,331,392.58. Following the completion of the transaction, the insider now directly owns 19,935 shares of the company’s stock, valued at approximately $2,819,207.70. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Gonzalo Uribe sold 1,780 shares of the firm’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $140.84, for a total transaction of $250,695.20. Following the completion of the transaction, the insider now directly owns 7,377 shares of the company’s stock, valued at approximately $1,038,976.68. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.62% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Price T Rowe Associates Inc. MD boosted its stake in Kimberly-Clark by 19.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 5,893,146 shares of the company’s stock worth $762,279,000 after buying an additional 944,920 shares during the period. Capital World Investors boosted its stake in Kimberly-Clark by 17.8% during the first quarter. Capital World Investors now owns 2,269,492 shares of the company’s stock worth $293,559,000 after buying an additional 342,790 shares during the period. Dimensional Fund Advisors LP boosted its stake in Kimberly-Clark by 22.4% during the second quarter. Dimensional Fund Advisors LP now owns 1,934,655 shares of the company’s stock worth $267,383,000 after buying an additional 354,501 shares during the period. Nordea Investment Management AB boosted its stake in Kimberly-Clark by 2.9% during the first quarter. Nordea Investment Management AB now owns 1,720,051 shares of the company’s stock worth $222,093,000 after buying an additional 48,103 shares during the period. Finally, Marshall Wace LLP boosted its stake in Kimberly-Clark by 48.4% during the second quarter. Marshall Wace LLP now owns 1,545,147 shares of the company’s stock worth $213,539,000 after buying an additional 503,839 shares during the period. 76.29% of the stock is owned by hedge funds and other institutional investors.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.